Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies

por Fergusson, Dean A., Wesch, Neil L., Leung, Garvin J., MacNeil, Jenna L., Conic, Isidora, Presseau, Justin, Cobey, Kelly D., Diallo, Jean-Simon, Auer, Rebecca, Kimmelman, Jonathan, Kekre, Natasha, El-Sayes, Nader, Krishnan, Ramya, Keller, Brian A., Ilkow, Carolina, Lalu, Manoj M.
Publicado 2019

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies

por Evgin, Laura, Ilkow, Carolina S, Bourgeois-Daigneault, Marie-Claude, de Souza, Christiano Tanese, Stubbert, Lawton, Huh, Michael S, Jennings, Victoria A, Marguerie, Monique, Acuna, Sergio A, Keller, Brian A, Lefebvre, Charles, Falls, Theresa, Le Boeuf, Fabrice, Auer, Rebecca A, Lambris, John D, McCart, J Andrea, Stojdl, David F, Bell, John C
Publicado 2016

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy

por Wedge, Marie-Eve, Jennings, Victoria A., Crupi, Mathieu J. F., Poutou, Joanna, Jamieson, Taylor, Pelin, Adrian, Pugliese, Giuseppe, de Souza, Christiano Tanese, Petryk, Julia, Laight, Brian J., Boileau, Meaghan, Taha, Zaid, Alluqmani, Nouf, McKay, Hayley E., Pikor, Larissa, Khan, Sarwat Tahsin, Azad, Taha, Rezaei, Reza, Austin, Bradley, He, Xiaohong, Mansfield, David, Rose, Elaine, Brown, Emily E. F., Crawford, Natalie, Alkayyal, Almohanad, Surendran, Abera, Singaravelu, Ragunath, Roy, Dominic G., Migneco, Gemma, McSweeney, Benjamin, Cottee, Mary Lynn, Jacobus, Egon J., Keller, Brian A., Yamaguchi, Takafumi N., Boutros, Paul C., Geoffrion, Michele, Rayner, Katey J., Chatterjee, Avijit, Auer, Rebecca C., Diallo, Jean-Simon, Gibbings, Derrick, tenOever, Benjamin R., Melcher, Alan, Bell, John C., Ilkow, Carolina S.
Publicado 2022